ask="100.00"
ask_size="200"
average_daily_volume="463298"
bid="84.50"
bid_size="100"
book_value="11.49"
change="+3.72"
change_from_200_day_moving_average="17.44"
change_from_50_day_moving_average="15.02"
change_from_52_week_high="-0.47"
change_From_52_week_low="42.28"
change_in_percent="+4.37%"
close="88.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.45"
ex_dividend_date="N/A"
float_shares="38556000"
high="89.27"
high_52_weeks="89.27"
last_trade_date="3/1/2017"
last_trade_price="88.80"
last_trade_size="54616"
last_trade_time="4:00pm"
low="85.21"
low_52_weeks="46.52"
market_capitalization="3.71B"
moving_average_200_day="71.36"
moving_average_50_day="73.78"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="95.06"
open="86.93"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+24.44%"
percent_change_from_50_day_moving_average="+20.37%"
percent_change_from_52_week_high="-0.53%"
percent_change_from_52_week_low="+90.89%"
previous_close="85.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.40"
price_per_sales="26692.09"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="15.47"
stock_exchange="NMS"
symbol="RARE"
volume="790714"
weeks_range_52="46.52 - 89.27"
